PNAA
BSX icon

Pictet North America Advisors’s Boston Scientific BSX Stock Holding History

Pictet North America Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.11M Buy
72,976
+273
+0.4% +$14.8K 0.27% 63
2026
Q1 		$4.56M Buy
72,703
+13,729
+23% +$1.1M 0.45% 53
2025
Q4 		$5.62M Sell
58,974
-2,355
-4% -$231K 0.53% 44
2025
Q3 		$5.99M Sell
61,329
-1,002
-2% -$104K 0.56% 41
2025
Q2 		$6.69M Sell
62,331
-6,967
-10% -$705K 0.67% 39
2025
Q1 		$6.99M Sell
69,298
-8,829
-11% -$889K 0.7% 41
2024
Q4 		$6.98M Buy
78,127
+1,837
+2% +$162K 0.66% 45
2024
Q3 		$6.39M Buy
76,290
+1,032
+1% +$81.4K 0.63% 42
2024
Q2 		$5.8M Buy
75,258
+2,531
+3% +$185K 0.63% 46
2024
Q1 		$4.98M Sell
72,727
-7,272
-9% -$468K 0.56% 40
2023
Q4 		$4.62M Sell
79,999
-298
-0.4% -$15.9K 0.6% 41
2023
Q3 		$4.24M Sell
80,297
-8,024
-9% -$421K 0.6% 40
2023
Q2 		$4.78M Buy
88,321
+1,931
+2% +$101K 0.66% 33
2023
Q1 		$4.32M Sell
86,390
-2,050
-2% -$96.6K 0.7% 34
2022
Q4 		$4.09M Sell
88,440
-5,099
-5% -$221K 0.7% 33
2022
Q3 		$3.62M Sell
93,539
-2,601
-3% -$104K 0.58% 35
2022
Q2 		$3.58M Sell
96,140
-4,298
-4% -$175K 0.47% 41
2022
Q1 		$4.45M Sell
100,438
-7,226
-7% -$313K 0.52% 39
2021
Q4 		$4.57M Buy
107,664
+4,020
+4% +$169K 0.45% 42
2021
Q3 		$4.5M Buy
103,644
+565
+0.5% +$25K 0.44% 43
2021
Q2 		$4.41M Buy
103,079
+980
+1% +$41.2K 0.46% 40
2021
Q1 		$3.95M Buy
102,099
+3,202
+3% +$121K 0.46% 42
2020
Q4 		$3.56M Buy
+98,897
New +$3.56M 0.45% 37

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pictet North America Advisors's BSX Position: Q2 2026 in Review

Pictet North America Advisors increased its Boston Scientific (BSX) stake by 0.38% in Q2 2026, buying an estimated $14.8K and bringing the position to 72,976 shares worth $3.11M. The position accounts for 0.27% of the portfolio, ranked #63.

Pictet North America Advisors first reported a position in BSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $6.99M in Q1 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pictet North America Advisors held 72,976 shares of Boston Scientific worth $3.11M as of Q2 2026.
  • Pictet North America Advisors bought 273 Boston Scientific shares in Q2 2026, an estimated $14.8K.
  • Boston Scientific made up 0.27% of Pictet North America Advisors's portfolio in Q2 2026, its #63 holding.
  • Pictet North America Advisors first reported a position in Boston Scientific in Q4 2020 and has held it in 23 quarters since.
  • Pictet North America Advisors's Boston Scientific position peaked at $6.99M in Q1 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pictet North America Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.